Zobrazeno 1 - 10
of 14
pro vyhledávání: '"RUNCHANA MARKMEE"'
Autor:
Runchana Markmee, Sirinda Aungsuchawan, Waleephan Tancharoen, Suteera Narakornsak, Peraphan Pothacharoen
Publikováno v:
Heliyon, Vol 6, Iss 9, Pp e04844- (2020)
Human amniotic fluid mesenchymal stem cells (hAF-MSCs) have been shown to be effective in the treatment of many diseases. Platelet lysate (PL) contains multiple growth and differentiation factors; therefore, it can be used as a differentiation induce
Externí odkaz:
https://doaj.org/article/fed637bb4ede4c74a6d57a7ee247229b
Autor:
Waleephan Tancharoen, Sirinda Aungsuchawan, Runchana Markmee, Suteera Narakornsak, Peraphan Pothacharoen
Publikováno v:
Heliyon, Vol 6, Iss 9, Pp e04873- (2020)
To differentiate stem cells into endothelial cells, vascular endothelia growth factors (VEGF) serve as the major signal for stimulating the cells. However, there are other cytokines or growth factors associated with endothelial cell development and d
Externí odkaz:
https://doaj.org/article/5a2ac0bd8f644435989e31794df6c81d
Autor:
Runchana Markmee, Sirinda Aungsuchawan, Peraphan Pothacharoen, Waleephan Tancharoen, Suteera Narakornsak, Tanongsak Laowanitwattana, Kanokkan Bumroongkit, Chaniporn Puaninta, Nathaporn Pangjaidee
Publikováno v:
Heliyon, Vol 5, Iss 7, Pp e02018- (2019)
The aim of this study was to evaluate the efficiency of ascorbic acid (AA) on cell viability, cytotoxicity and the effects on cardiomyogenic differentiation of the human amniotic fluid mesenchymal stem cells (hAF-MSCs). The results of methylthiazole
Externí odkaz:
https://doaj.org/article/5ad253cdf5024d3aa45ebdb2a69ce973
Autor:
Suteera Narakornsak, Sirinda Aungsuchawan, Peraphan Pothacharoen, Kanokkan Bumroongkit, Waleephan Tancharoen, Nathaporn Pangjaidee, Tanongsak Laowanitwattana, Chaniporn Puaninta, Chawapon Thaojamnong, Runchana Markmee
Publikováno v:
Molecular Medicine Reports
Human amniotic fluid (hAF) mesenchymal stem cells (MSCs) are commonly cultured in medium containing FBS. However, there are concerns about using animal serum in therapeutic applications due to the potential for immunogenic reactions and the risk of t
Autor:
Peraphan Pothacharoen, Naree Poovachiranon, Sirinda Aungsuchawan, Runchana Markmee, Suteera Narakornsak, Tanongsak Laowanitwattana, Chaniporn Puaninta, Chawapon Thaojamnong, Waleephan Tancharoen
Publikováno v:
Acta Histochemica. 121:72-83
Mesenchymal stem cells (MSCs), which possess remarkable capabilities, are found in amniotic fluid (AF). The findings of several studies have shown the potential benefits of these cells in applications of regenerative medicine. In clinical application
Autor:
Waleephan Tancharoen, Sirinda Aungsuchawan, Suteera Narakornsak, Peraphan Pothacharoen, Runchana Markmee
Publikováno v:
Heliyon, Vol 6, Iss 9, Pp e04844-(2020)
Heliyon
Heliyon
Human amniotic fluid mesenchymal stem cells (hAF-MSCs) have been shown to be effective in the treatment of many diseases. Platelet lysate (PL) contains multiple growth and differentiation factors; therefore, it can be used as a differentiation induce
Autor:
Peraphan Pothacharoen, Sirinda Aungsuchawan, Suteera Narakornsak, Waleephan Tancharoen, Runchana Markmee
Publikováno v:
Heliyon
Heliyon, Vol 6, Iss 9, Pp e04873-(2020)
Heliyon, Vol 6, Iss 9, Pp e04873-(2020)
To differentiate stem cells into endothelial cells, vascular endothelia growth factors (VEGF) serve as the major signal for stimulating the cells. However, there are other cytokines or growth factors associated with endothelial cell development and d
Autor:
Suteera Narakornsak, Waleephan Tancharoen, Nathaporn Pangjaidee, Lamaiporn Peerapapong, Sirinda Aungsuchawan, Tanongsak Laowanitwattana, Peeraphan Pothacharoen, Runchana Markmee, Witoon Tasuya, Nonglak Boonma, Junjira Keawdee
Publikováno v:
Acta Histochemica. 120:701-712
Osteoporosis is a bone degenerative disease characterized by a decrease in bone strength and an alteration in the osseous micro-architecture causing an increase in the risk of fractures. These diseases usually happen in post-menopausal women and elde
Autor:
RUNCHANA MARKMEE1, AUNGSUCHAWAN, SIRINDA1, NARAKORNSAK, SUTEERA1, WALEEPHAN TANCHAROEN1, KANOKKARN BUMRUNGKIT1, NATAPORN PANGCHAIDEE1, CHANIPORN PUANINTA1, PERAPHAN POTHACHAROEN2
Publikováno v:
Molecular Medicine Reports. Nov2017, Vol. 16 Issue 5, p6068-6076. 9p. 2 Color Photographs, 1 Chart, 3 Graphs.
Autor:
Kanokkarn Bumrungkit, Sirinda Aungsuchawan, Runchana Markmee, Suteera Narakornsak, Nataporn Pangchaidee, Chaniporn Puaninta, Waleephan Tancharoen, Peraphan Pothacharoen
Publikováno v:
Molecular Medicine Reports
Ischemic heart disease (IHD) is a major factor influencing worldwide mortality rates. Furthermore, IHD has become a significant health problem among the Thai population. Stem cell therapy using mesenchymal stem cells (MSCs) is an alternative therapeu